Somerset Group’s Pfizer PFE Stock Holding History

Somerset Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,352	Closed	-$211K	–	65
2023 Q3	$211K	Hold	6,352	–	–	0.2%	63
2023 Q2	$233K	Sell	6,352 -197	-3%	-$7.67K	0.19%	64
2023 Q1	$267K	Hold	6,549	–	–	0.23%	58
2022 Q4	$336K	Sell	6,549 -2	-0%	-$96	0.3%	51
2022 Q3	$287K	Buy	6,551 +2	+0%	+$97	0.26%	52
2022 Q2	$343K	Hold	6,549	–	–	0.3%	52
2022 Q1	$339K	Hold	6,549	–	–	0.24%	55
2021 Q4	$387K	Hold	6,549	–	–	0.26%	55
2021 Q3	$282K	Hold	6,549	–	–	0.2%	63
2021 Q2	$256K	Buy	6,549 +197	+3%	+$7.66K	0.18%	70
2021 Q1	$230K	Buy	+6,352	New	+$226K	0.17%	73
2020 Q1	–	Sell	-5,692	Closed	-$212K	–	65
2019 Q4	$212K	Sell	5,692 -375	-6%	-$13.4K	0.18%	66
2019 Q3	$207K	Hold	6,067	–	–	0.18%	66
2019 Q2	$249K	Hold	6,067	–	–	0.21%	61
2019 Q1	$244K	Hold	6,067	–	–	0.2%	60
2018 Q4	$251K	Hold	6,067	–	–	0.25%	55
2018 Q3	$254K	Buy	+6,067	New	+$234K	0.2%	62

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Somerset Group's PFE Position: Q4 2023 in Review

Somerset Group sold out of Pfizer (PFE) in Q4 2023, closing a stake of 6,352 shares — an estimated $211K sold.

Somerset Group first reported a position in PFE in Q3 2018 and held it in 17 quarters. The position peaked at $387K in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Somerset Group reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Somerset Group sold 6,352 Pfizer shares in Q4 2023, an estimated $211K.
Somerset Group first reported a position in Pfizer in Q3 2018 and held it in 17 quarters.
Somerset Group's Pfizer position peaked at $387K in Q4 2021.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Somerset Group's 13F filing for Q4 2023, filed 12 Feb 2024.